glp-1 neurotransmitter From metabolism to mind: The expanding role of the receptor in neurotherapeutics Glucagon-like peptide 1 (GLP-1) -

Astrocyte dysfunction is a common feature of neurodegenerative diseases such as Alzheimers disease (AD), Parkinsons disease (PD) and amyotrophic lateral sclerosis (ALS)

Its catchy

Efficacy and safety of once-weekly cagrilintide for weight management: a randomised, placebo and active-controlled, dose-finding phase 2 trial Summary: This Phase 2 dose-finding trial investigated the efficacy and safety of cagrilintide monotherapy for weight management

2019;36(Suppl 2):59-71

Early Diagnosis and Intervention One of the most significant advantages of genetic testing is the ability to diagnose GSD early

doi:10.3389/fpsyt.2021.546801 8